LXRX
Lexicon Pharmaceuticals Inc
1.90$
+5.8%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +468.9% | -35.9% | +8.4% | -30.0% | +409.5% | -92.5% | -98.8% | -53.4% | +766.2% | +2,481.5% | +60.2% | |
| – | +6.6% | +72.3% | -98.8% | +31.2% | +29.7% | -40.3% | +2,753.6% | -4.6% | +12.3% | -99.0% | -55.5% | |
| – | – | -331.5% | – | -31.3% | +425.1% | -93.1% | -348.1% | – | – | – | +62.6% | |
| – | +6.6% | +87.2% | -12.0% | -36.1% | -8.3% | +67.1% | -64.2% | -4.1% | +11.5% | +43.5% | -27.7% | |
| – | +22.8% | +80.6% | +53.8% | -3.7% | -10.9% | -99.9% | +68,377.7% | +48.7% | +103.2% | +46.5% | -73.9% | |
| – | +9.5% | +85.8% | +0.8% | -26.5% | +8.2% | -60.6% | -53.7% | +49.6% | +135.6% | +99.7% | -56.7% | |
| – | – | -9,443.0% | – | – | – | -133.8% | – | – | – | – | – | |
| – | +198.4% | -2.3% | +6.3% | +197.5% | -0.5% | -29.7% | -94.5% | +246.6% | +371.3% | +18.9% | -46.5% | |
| – | – | – | – | – | – | -147.2% | – | – | – | – | – | |
| – | – | -24.8% | -380.7% | – | -271.4% | – | -95.6% | +132.2% | -67.4% | -52,003.8% | – | |
| – | – | – | – | – | – | -145.0% | – | – | – | – | – | |
| – | – | -1,173.6% | – | – | – | -127.7% | – | – | – | – | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.